UK markets closed

VBI Vaccines Inc. (VBIV)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6300-0.0196 (-3.02%)
At close: 04:00PM EDT
0.6103 -0.02 (-3.13%)
After hours: 07:31PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-110,945
-92,836
-113,303
-69,753
-46,230
Depreciation & amortisation
2,010
1,990
2,061
1,835
1,652
Stock-based compensation
9,908
6,661
9,698
9,628
5,287
Change in working capital
-3,704
-10,050
-1,314
16,773
-9,160
Accounts receivable
-98
99
-87
69
130
Inventory
-4,509
-3,718
-5,690
-513
-1,946
Accounts payable
7,952
-6,652
8,893
356
2,059
Other working capital
-76,667
-61,750
-78,039
-41,903
-48,050
Other non-cash items
465
475
360
1,931
386
Net cash provided by operating activities
-73,165
-60,883
-73,695
-39,908
-47,050
Cash flows from investing activities
Investments in property, plant and equipment
-3,502
-867
-4,344
-1,995
-1,000
Purchases of investments
-
-
-
-
-25,000
Sales/maturities of investments
0
-
0
25,151
-
Net cash used for investing activities
-3,502
-867
-4,344
23,156
-26,000
Cash flows from financing activities
Debt repayment
-
-
-
0
-15,300
Common stock issued
3,034
24,273
12
33,293
122,186
Other financing activities
-693
-1,575
-563
-1,089
-6,633
Net cash used provided by (used for) financing activities
22,341
22,698
19,449
44,293
122,392
Net change in cash
-53,920
-38,944
-59,065
27,869
-49,612
Cash at beginning of period
137,470
62,629
121,694
93,825
44,213
Cash at end of period
83,144
23,685
62,629
121,694
93,825
Free cash flow
Operating cash flow
-73,165
-60,883
-73,695
-39,908
-47,050
Capital expenditure
-3,502
-867
-4,344
-1,995
-1,000
Free cash flow
-76,667
-61,750
-78,039
-41,903
-48,050